Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3105 results found
Expand All
Apply All
3105 results found

BIO Signs on to Letter Urging Federal Government to Protect Essential Workers
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  April 14, 2020
We support prioritizing the healthcare sector for COVID-19 testing supplies, and as testing becomes more available and abundant, the undersigned organizations urge the federal government to provide COVID-19 testing resources to U.S. employers that are engaged in essential business services. Increased access to COVID-19 testing for our workforce will help flatten the curve by removing people with coronavirus from the workplace and better ensure the safety and health of employees who are maintaining operations during this pandemic.
Read More

The latest on CAR T-cell reimbursement
Share
Good Day BIO Newsletter  •  April 14, 2020
Here's something cool. Music-minded scientists have assigned a unique musical note to each amino acid in the coronavirus, turning it into an eerily beautiful song—which could help them discover antibodies or drugs to treat it. Today, we’re taking a quick break from the coronavirus to look at what people are saying about the CAR T-cell reimbursement issue, as well as Mazda’s biofuels initiative and the latest on when Congress will return from recess, in about 615 words (3 minutes).
Read More

Letters, Testimony, & Comments
Share

Small biotech, big news
Share
Good Day BIO Newsletter  •  April 13, 2020
We’re starting a new week on an upbeat note, with news from biotech companies large and small on how they are making a difference in the COVID-19 fight. As BIO’s Chair Dr. Jeremy Levin says, this is the industry’s “finest hour.” Here are about 680 words, or 3 minutes, 20 seconds.
Read More

“We’re closer than people think.”
Share
Good Day BIO Newsletter  •  April 10, 2020
The bad news? There’s been a detection of bird flu in the United States. The even worse news? Dolly Parton is unaware that over 50+ biotech innovators are working around the clock to beat COVID-19. Help us spread the word by RETWEETING our message to Dolly! You can do so by clicking here.As for the good news, we know how to protect against animal diseases. And we’re very close to COVID-19 treatments and vaccines. Here’s a quick 662 words, or about 3 minutes, 20 seconds.
Read More

Letter Urging USDA to Include Biofuels in COVID-19 Economic Relief
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  April 9, 2020
Given the impact the economic downturn has had on all biofuel technologies, we request that USDA ensures all advanced and cellulosic biofuels are eligible to receive assistance from the additional funds provided to the Commodity Credit Corporation (CCC) by the Coronavirus Aid, Relief, and Economic Stabilization (CARES) Act. 
Read More

BIO's Coronavirus Hub has 1,000+ users
Share
Good Day BIO Newsletter  •  April 9, 2020
Today marks 100 days since China announced the detection of the coronavirus (H/T Axios/The Guardian).  We also have a milestone to report: the BIO Coronavirus Hub has 1,000 users. More on that, plus how we can ensure the continuity of the food supply chain, in around 900 words, or 4-and-a-half minutes.P.S. We're thinking of our readers celebrating Passover, Holy Week, and Easter. With so much going on in our industry, we are continuing business as usual at Good Day BIO in the coming days, but we are wishing you all a joyous holiday and hope you enjoy time with your families, virtually.
Read More

2 cool things: animal biotech and antibodies
Share
Good Day BIO Newsletter  •  April 8, 2020
Congratulations to the several BIO members who were included in Endpoints News’ 20 Under 40 in Biopharma! We’re proud to be working with so many next-generation biotech leaders.  Today, we take a closer look at how animal biotech policy can help us fight coronavirus, as well as answer some of your questions about antibodies, in about 860 words, just over 4 minutes.
Read More

BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19
Share
Food & Farm Innovation  •  Letters, Testimony & Comments  •  April 7, 2020
As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.
Read More

On World Health Day, a reminder of why collaboration matters
Share
Good Day BIO Newsletter  •  April 7, 2020
It’s World Health Day, a public health awareness day promoted by the World Health Organization (WHO)—and this year’s theme celebrates nurses and midwives, many of whom are caring for patients on the frontlines of the COVID-19 pandemic. We’re thinking of you today, and every day, as we race to find therapeutics and vaccines and deliver diagnostics and other tools and supplies for you to do your jobs safely. Today, we’re looking at one example of how international collaboration is doing just that, plus, why you don’t need to worry about running out of food. Here are 850 words, just over 4 minutes.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 229
  • 230
  • 231
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO